When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
STML - Stemline's 'pipeline in a product' merits Overweight rating at Cantor
Stemline Therapeutics Inc.
Stemline Therapeutics (NASDAQ:STML) +3% pre-market after Cantor Fitzgerald initiates coverage with an Overweight rating and $18 price target, saying Elzonris could be a "pipeline in a product" for the company and is underappreciated by investors.
More news on: Stemline Therapeutics, Inc., Healthcare stocks news, Stocks on the move,